Dr. Jeffrey L Marks , MD
Urology • Plantation, FL
7390 Nw 5th St, Suite 7
Plantation, FL 333171610
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 16, 2006; this date does not establish years in practice.
-
Published CMS data list 8,285 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 81000 — Manual urinalysis test with examination using microscope, non-automated: 2,053 service units.
- 99214 — Established patient outpatient office visit: 1,837 service units.
- 51741 — Electronic assessment of bladder emptying: 1,129 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 24 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 8,201 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 2,347 prescription fills, including refills.
- Finasteride — 990 prescription fills, including refills.
- Myrbetriq (Mirabegron) — 480 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 51 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 85% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: 1,418. Middle half: 564 to 4,602.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 7,850 in 2020 to 8,285 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
7390 Nw 5th St
Suite 7
Plantation, FL 333171610
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Baylor College Of Medicine
1983
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
950 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $590,238 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $448,509 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
16,705 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,606,747 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,544.60 across 57 records.
By nature of payment
- Food and Beverage: $1,476.60 across 56 records.
- Education: $68.00 across 1 record.
Reporting-company totals (3 largest of 23)
- Antares Pharma, Inc.: $159.15 across 8 records.
- Novartis Pharmaceuticals Corporation: $158.98 across 2 records.
- Sumitomo Pharma America, Inc.: $157.34 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
43 years (graduated 1983)
CMS Doctors and Clinicians data list 1983 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Marks has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Marks as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Plantation and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 85% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: 1,418. Middle half: 564 to 4,602.
Too few clinicians listed under Urology in Plantation have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: $124,097. Middle half: $52,476 to $268,577.
Too few clinicians listed under Urology in Plantation have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: $92,445. Middle half: $39,067 to $203,147.
Too few clinicians listed under Urology in Plantation have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Urology in Florida (2024, 735 clinicians with data). Median for this group: 1,304. Middle half: 361 to 2,294.
Too few clinicians listed under Urology in Plantation have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Florida (2024, 735 clinicians with data). Median for this group: $135,374. Middle half: $24,342 to $465,517.
Too few clinicians listed under Urology in Plantation have Medicare Part D data for 2024 to compare.
7 active clinicians are listed under Urology with a practice address in Plantation, FL (1,039 in Florida).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 7,850 in 2020 and 8,285 in 2024.
- 2020: 7,850
- 2021: 8,839
- 2022: 9,070
- 2023: 8,627
- 2024: 8,285
-
Medicare-allowed amount
Medicare-allowed amount increased 15% from $512,190 in 2020 to $590,238 in 2024.
- 2020: $512,190
- 2021: $640,696
- 2022: $646,395
- 2023: $585,844
- 2024: $590,238
-
Paid by Medicare
Paid by Medicare increased 16% from $387,463 in 2020 to $448,509 in 2024.
- 2020: $387,463
- 2021: $487,788
- 2022: $486,693
- 2023: $438,231
- 2024: $448,509
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 14% from 7,191 in 2020 to 8,201 in 2024.
- 2020: 7,191
- 2021: 7,514
- 2022: 7,882
- 2023: 8,261
- 2024: 8,201
-
30-day fills
30-day fills increased 20% from 13,880 in 2020 to 16,705 in 2024.
- 2020: 13,880
- 2021: 14,716
- 2022: 15,768
- 2023: 16,529
- 2024: 16,705
-
Part D drug cost
Part D drug cost increased 53% from $1,051,786 in 2020 to $1,606,747 in 2024.
- 2020: $1,051,786
- 2021: $856,925
- 2022: $1,570,383
- 2023: $1,543,432
- 2024: $1,606,747
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 36% from $2,419.96 in 2021 to $1,544.60 in 2025.
- 2021: $2,419.96
- 2022: $6,052.61
- 2023: $1,470.57
- 2024: $1,018.96
- 2025: $1,544.60
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 57 records totaling $1,544.60.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $134.29 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Padcev | General | $125.00 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
ERLEADA | General | $68.00 |
| Myriad Genetic Laboratories, Inc. |
Food and Beverage
In-kind items and services
|
PROLARIS | General | $54.30 |
| BLUEWIND MEDICAL |
Food and Beverage
In-kind items and services
|
REVI | General | $38.83 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
XIAFLEX | General | $35.40 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $29.30 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $29.06 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $28.67 |
| HOLOGIC INC |
Food and Beverage
In-kind items and services
|
APTIMA | General | $28.39 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $27.94 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $27.73 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $27.61 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.36 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $25.90 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Trelstar | General | $25.87 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $25.72 |
| ACCORD HEALTHCARE, INC. |
Food and Beverage
In-kind items and services
|
Camcevi | General | $25.40 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Tlando | General | $25.22 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $25.07 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Trelstar | General | $24.97 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $24.84 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $24.80 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $24.69 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $24.66 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
81000
Manual urinalysis test with examination using microscope, non-automated
|
2,053 | 913 | $20.00 | $3.93 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,837 | 854 | $165.00 | $136.87 |
|
51741
Electronic assessment of bladder emptying
|
1,129 | 701 | $150.00 | $14.47 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
1,121 | 648 | $50.00 | $11.99 |
|
76775
Limited ultrasound scan behind abdominal cavity
|
916 | 673 | $150.00 | $63.01 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
146 | 146 | $225.00 | $179.83 |
|
99459
Pelvic exam
|
129 | 99 | $50.00 | $23.59 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
128 | 14 | $500.00 | $178.49 |
|
51729
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies
|
109 | 108 | $700.00 | $298.76 |
|
51797
Insertion of device into abdomen with pressure and urine flow rate study
|
109 | 108 | $175.00 | $183.53 |
|
52224
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm
|
105 | 92 | $1500.00 | $815.46 |
|
36415
Insertion of needle into vein for collection of blood sample
|
102 | 86 | $10.00 | $8.57 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
93 | 76 | $300.00 | $188.58 |
|
51701
Insertion of temporary bladder tube
|
81 | 58 | $80.00 | $48.46 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
42 | 16 | $125.00 | $84.40 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
33 | 14 | $60.00 | $37.30 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
26 | 17 | $125.00 | $97.12 |
|
76872
Ultrasound scan of pelvic region through rectum
|
22 | 22 | $200.00 | $144.65 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
22 | 17 | $200.00 | $140.23 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
22 | 11 | $10.00 | $0.46 |
|
51700
Simple bladder irrigation and/or instillation
|
21 | 16 | $125.00 | $81.43 |
|
55700
Biopsy of prostate gland
|
14 | 14 | $450.00 | $256.71 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
13 | 13 | $180.00 | $174.25 |
|
52214
Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope
|
12 | 12 | $1500.00 | $785.21 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 2,347 | 188,182 | $24,378.26 | 798 |
| Finasteride | Finasteride | 990 | 84,250 | $11,326.90 | 338 |
| Myrbetriq | Mirabegron | 480 | 21,610 | $322,679.84 | 148 |
| Gemtesa | Vibegron | 426 | 19,839 | $314,096.12 | 131 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 337 | 3,274 | $2,967.42 | 244 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 263 | 19,926 | $4,896.10 | 81 |
| Doxycycline Hyclate | Doxycycline Hyclate | 261 | 2,780 | $2,262.24 | 197 |
| Sildenafil Citrate | Sildenafil Citrate | 256 | 9,204 | $1,609.66 | 84 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 254 | 1,621 | $1,273.58 | 215 |
| Bicalutamide | Bicalutamide | 170 | 10,689 | $6,257.55 | 59 |
| Desmopressin Acetate | Desmopressin Acetate | 161 | 9,645 | $6,648.94 | 68 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 140 | 11,284 | $3,183.51 | 51 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 133 | 1,168 | $1,875.66 | 94 |
| Solifenacin Succinate | Solifenacin Succinate | 128 | 7,771 | $5,349.36 | 54 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 125 | 3,182 | $2,847.28 | 78 |
| Lupron Depot | Leuprolide Acetate | 124 | 3,586 | $261,439.34 | 21 |
| Estradiol | Estradiol | 96 | 7,237 | $5,279.10 | 60 |
| Silodosin | Silodosin | 96 | 6,323 | $7,446.94 | 37 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 94 | 915 | $356.92 | 79 |
| Levofloxacin | Levofloxacin | 91 | 1,000 | $419.67 | 81 |
| Testosterone Cypionate | Testosterone Cypionate | 88 | 5,364 | $4,339.19 | 25 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 77 | 4,795 | $7,707.10 | 26 |
| Cephalexin | Cephalexin | 73 | 483 | $283.88 | 65 |
| Dutasteride | Dutasteride | 73 | 5,941 | $2,900.22 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 67 | 5,497 | $776.16 | 21 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-11-13NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20110331000900
FL
1658445317
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Urology (license number reported to NPPES: FL 57712)
NPI status registered as active in NPPES database
Registered at 7390 NW 5TH ST, SUITE 7, PLANTATION, FL 333171610 (Tel: 9545877010)
Registered at 7390 NW 5TH ST, SUITE 7, PLANTATION, FL 333171610 (Tel: 9545877010)
Recorded as JEFFREY MARKS, MD
Urology (license number reported to NPPES: FL ME0057712)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Plantation
- Dr. Christopher Vendryes, MD, MS
- Dr. Paul Kahn, MD
- Dr. Jason Wolf, MD
- Dr. Daniel Ead, MD
- Patrick Villicana
Mailing Address
7390 Nw 5th St, Suite 7
Plantation, FL 333171610
Phone: 9545877010